MAY 24, 2019 2:01 PM PDT

Blocking this particular protein could slow prostate cancer

Castration-resistant prostate cancer (CRPC) is a particularly aggressive form of prostate cancer. Although the standard of care treatment, which involves disrupting androgen receptor (AR) signaling, is usually effective for 2-3 years, the treatment is not effective long-term and CRPC often develops into lethal metastases.

This is exactly why new research published in Molecular Cancer Research from scientists at Boston University School of Medicine (BUSM) is so exciting. Led by Gerald V. Denis PhD, the BUSM team has determined that blocking a particular protein could prevent the CRPC growth.

"Our findings are significant because current therapeutic options for CRPC are limited and focus primarily on suppressing prostate tumor cells that rely on AR signaling," explained first author Jordan Shafran. "Therefore, it is imperative to identify 'druggable' targets that regulate prostate cancer cell migration and invasion in cells that are either reliant on, or independent of, androgen receptor signaling," he added.

The group of proteins that the researchers investigated is called BET bromodomain proteins and consists of BRD2, BRD3 and BRD4, which regulate gene expression. Following the study’s results, inhibiting the protein BRD4 consistently regulated prostate cancer cell migration and invasion. The same was not found for the proteins BRD2 or BRD3.

The authors elaborate, writing, “We found that BRD4 regulates cell migration across all models of CRPC, regardless of aggressiveness and AR status, whereas BRD2 and BRD3 only regulate migration and invasion in less aggressive models that retain AR expression or signaling. BRD4, a co-regulator of gene transcription, controls migration and invasion through transcription of AHNAK, a large scaffolding protein linked to [the] promotion of metastasis in a diverse set of cancers. Furthermore, treatment of CRPC cell lines with low doses of MZ1, a small-molecule, BRD4-selective degrader, inhibits metastatic potential.”

CRPC is a particularly aggressive form of cancer. Photo: Pixabay

This discovery could have significant implications for the future of CRPC treatments and could offer a new targetable pathway to treat metastatic CRPC, according to the authors.

Sources: Science Daily, Molecular Cancer Research

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
MAY 11, 2020
Cancer
Using Deep Learning to Diagnose Breast Cancer Sub-Types
MAY 11, 2020
Using Deep Learning to Diagnose Breast Cancer Sub-Types
Cancer and computer programming may not sound like two things that go together. However, advanced programming techniques ...
MAY 03, 2020
Cancer
New genes targeted for anti-cancer therapies
MAY 03, 2020
New genes targeted for anti-cancer therapies
Research published in the journal Genome Biology reports the discovery of two overlooked genes that have the potential t ...
JUN 01, 2020
Cancer
A New RNA in Fine-Tuned Signal Regulation
JUN 01, 2020
A New RNA in Fine-Tuned Signal Regulation
In a healthy cell, many complex networks work to make sure everything runs as it should. Some of these networks function ...
JUN 04, 2020
Immunology
Tissue Stiffness Regulates Immune Responses
JUN 04, 2020
Tissue Stiffness Regulates Immune Responses
  Cells are remarkably sensitive to the mechanical properties of their environment, changing their behavior as a re ...
JUN 14, 2020
Chemistry & Physics
Why Are There So Few Black People in STEM?
JUN 14, 2020
Why Are There So Few Black People in STEM?
On June 10th, 2020, thousands of STEM scientists and organizations around the world went on strike to protest systemic r ...
JUL 10, 2020
Cancer
Researching New RNA Biomarkers for Liver Cancer
JUL 10, 2020
Researching New RNA Biomarkers for Liver Cancer
The most important part of cancer treatment is the first step, diagnosis. Many cancers can lie dormant for years, reachi ...
Loading Comments...